Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database
Aspirin is associated with reduced 28-day mortality in CAP patients. However, 325 mg/day aspirin does not provide extra benefits over 81 mg/day and may lead to longer ICU stays.
Authors
- Xue Cheng
- Tinghua Hu (ORCID: https://orcid.org/0000-0002-8506-6302)
- Jiaolin Sun
- Xiaohui Yu (ORCID: https://orcid.org/0000-0001-8170-2327)
- Wenwen Ji
- Tingting Liu (ORCID: https://orcid.org/0000-0001-6396-7225)
- Na Wang (ORCID: https://orcid.org/0000-0002-8312-9787)
- Yaxin Zhang (ORCID: https://orcid.org/0000-0002-9533-1472)
- Guangdong Wang (ORCID: https://orcid.org/0000-0001-7237-3517)
- Lin Lv (ORCID: https://orcid.org/0000-0002-5253-1669)
- Zhihong Shi (ORCID: https://orcid.org/0000-0002-5743-5158)
- Mengchong Li
Institutions
- Fujian Medical University (CN)
- Shanxi Medical University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Shanxi Provincial Children's Hospital (CN)
- Shanxi Provincial People’s Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fphar.2024.1402386
- Citations
- 3
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- National Key Research and Development Program of China